Non-invasive Prenatal Testing Market Growth with Trends, CAGR of 13.80%, Analysis by Type, Application, Regions, Restraints, Top Key Players Profile and forecast to 2029

Non-Invasive Prenatal Testing Market research report has been prepared with the systematic gathering and assessment of market information for Healthcare industry. Moreover, it highlights both qualitative and quantitative techniques of market analysis where focus groups or in-depth interviews and customer survey or analysis of secondary data has been conducted respectively. While preparing this Non-Invasive Prenatal Testing Market document, research and analysis has been performed with one step or the combination of several steps depending upon the business and client requirements. Market shares of the major industry players in the key areas of the globe such as Europe, North America, Asia Pacific, South America, Middle East and Africa are also conducted.
After introducing next-generation sequencing technology, it is now possible to sequence foetal DNA fragments that can be built into a whole genetic map, allowing the foetal genome to be inspected prenatally and non-invasively. Novel screening approaches for foetal chromosomal aneuploidies have been developed as a result of advances in molecular technologies and the identification of cell-free foetal DNA in maternal plasma.

Data Bridge Market Research analyses that the non-invasive prenatal testing market which was USD 3.22 billion in 2021, would rocket up to USD 9.06 billion by 2029, and is expected to undergo a CAGR of 13.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-non-invasive-prenatal-testing-market

Non-invasive prenatal testing is a DNA-based blood test that is used to assess the risk of genetic disorders in the developing foetus. This is done to see if you have Down syndrome, Patau syndrome, or Edwards syndrome, among other things.

Non-invasive Prenatal Testing Market Dynamics
Drivers

• High risk of chromosomal abnormalities with increasing maternal age
The age of a woman at the time of delivery is referred to as her maternal age. Increasing maternal age can lead to a variety of health issues, including reduced fertility, high blood pressure, and an increased chance of miscarriage, stillbirths, and maternal mortality. Furthermore, as a result of faulty chromosomal division, maternal age can raise the incidence of genetic abnormalities in newborns. Microcephaly, a short neck, upward slanted eyes, weak muscular tone, and heart, intestinal, and breathing difficulties are all possible outcomes in neonates. These data imply that there has been an increase in maternal advanced age over the world, which is likely to lead to more health issues. Thus, the increasing maternal age, coupled with the increasing incidence of chromosomal abnormalities, is expected to drive the demand for NIPT tests.

• Growing incidence of chromosomal abnormalities
The rising frequency of chromosomal abnormalities, as well as increased product utilisation in new applications, are driving the market's organic revenue growth. Furthermore, innovations in existing tests in terms of expanded functionality, improved chemistry, and bioinformatics analysis are projected to drive market growth. The improvement of payment policies for ordinary and low-risk pregnancies is one of the market's primary driving forces. Natera announced in December 2020 that its non-invasive prenatal testing (NIPT) would be covered for all pregnancies by Aetna, the leading U.S. health insurer.

• High incidence rate of down syndrome
One of the key factors driving the market for non-invasive prenatal testing (NIPT) is the rise in average maternal age, which has raised concerns about the fetus's safety. Down syndrome is a chromosomal disorder in which an extra chromosome 21 is formed as a result of a cell division error, and it can damage a foetus' cognitive abilities and physical growth. The NIPT screening tests are safe for both the mother and the baby, pose no risk of miscarriage, and can detect more than 99 percent of Down syndrome instances. According to the National Down Syndrome Society and the Centers for Disease Control and Prevention, one out of every 700 babies in the United States is born with Down syndrome, and 80 percent of Down syndrome children are born to older moms. The increased risk of having babies with Down syndrome among older women drives the non-invasive prenatal testing market.

Global Non-invasive Prenatal Testing Market Scope
The non-invasive prenatal testing market is segmented on the basis of product, method, application, test type, technology and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product
• Products
• Consumables
• Assay Kits and Reagents
• Disposables
• Instruments
• NGS Systems
• PCR Instruments
• Microarrays
• Ultrasound Devices
• Other Instruments
• Services

Method
• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Tests

Application
• Trisomy
• Microdeletion Syndrome
• Other Applications

Test Type
• Materni21
• Harmony
• Panorama
• Verify
• NIFTY
• Others

Technology
• NGS
• WGS
• Others

End-User
• Diagnostic Laboratories
• Hospitals

Core Objective of Non-Invasive Prenatal Testing Market:
Every firm in the Non-Invasive Prenatal Testing Market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.

• Non-Invasive Prenatal Testing Market Size and growth rate factors.
• Important changes in the future Non-Invasive Prenatal Testing Market.
• Top worldwide competitors of the Market.
• Scope and product outlook of Non-Invasive Prenatal Testing Market.
• Developing regions with potential growth in the future.
• Tough Challenges and risk faced in Market.
• Non-Invasive Prenatal Testing top manufacturers profile and sales statistics.

Browse More Reports
https://dbmrmarkett.blogspot.com/2023/11/respiratory-care-devices-market-set-to.html
https://dbmrmarkett.blogspot.com/2023/11/europe-surgical-robots-market-to.html
https://dbmrmarkett.blogspot.com/2023/11/tele-intensive-care-unit-icu-market.html
https://dbmrmarkett.blogspot.com/2023/11/peanut-allergy-treatment-market-growing.html

About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. "Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com